Clinical Trials Logo

Clinical Trial Summary

Patients who undergoing total knee arthroplasty under spinal analgesia will be recruited and randomly assigned to the following two groups according to the regimen of PCA: (A) opioid group who receive only fentanyl citrate 1200mcg for continuous infusion drug, (B) non-opioid group who receive ketorolac tromethamine 150mg with nefopam hydrochloride 100mg for continuous infusion drug. All the patients will receive additional fentanyl citrate as bolus injection drug if they need more analgesics postoperatively.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05861791
Study type Interventional
Source Chung-Ang University Gwangmyeong Hospital
Contact Se-Hee Min
Phone 821054004892
Email seiheemin@gmail.com
Status Recruiting
Phase N/A
Start date February 7, 2023
Completion date February 7, 2024